Literature DB >> 32846140

Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis.

Jungwoo Wren Kim1, Xiling Yin2, Aanishaa Jhaldiyal3, Mohammed Repon Khan2, Ian Martin2, Zhong Xie4, Tamara Perez-Rosello4, Manoj Kumar2, Leire Abalde-Atristain5, Jinchong Xu2, Li Chen2, Stephen M Eacker6, D James Surmeier4, Nicholas T Ingolia7, Ted M Dawson8, Valina L Dawson9.   

Abstract

The G2019S mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause of familial Parkinson's disease (PD). This mutation results in dopaminergic neurodegeneration via dysregulated protein translation, although how alterations in protein synthesis contribute to neurodegeneration in human neurons is not known. Here we define the translational landscape in LRRK2-mutant dopaminergic neurons derived from human induced pluripotent stem cells (hiPSCs) via ribosome profiling. We found that mRNAs that have complex secondary structure in the 5' untranslated region (UTR) are translated more efficiently in G2019S LRRK2 neurons. This leads to the enhanced translation of multiple genes involved in Ca2+ regulation and to increased Ca2+ influx and elevated intracellular Ca2+ levels, a major contributor to PD pathogenesis. This study reveals a link between dysregulated translation control and Ca2+ homeostasis in G2019S LRRK2 human dopamine neurons, which potentially contributes to the progressive and selective dopaminergic neurotoxicity in PD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5′ UTR; LRRK2; Parkinson’s disease; RPS15; calcium homeostasis; ribosome profiling; translatome; uS19

Mesh:

Substances:

Year:  2020        PMID: 32846140      PMCID: PMC7542555          DOI: 10.1016/j.stem.2020.08.002

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  63 in total

1.  Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.

Authors:  R E Dolmetsch; U Pajvani; K Fife; J M Spotts; M E Greenberg
Journal:  Science       Date:  2001-10-12       Impact factor: 47.728

2.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

3.  An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.

Authors:  Manabu Funayama; Kazuko Hasegawa; Etsuro Ohta; Noriko Kawashima; Masaru Komiyama; Hisayuki Kowa; Shoji Tsuji; Fumiya Obata
Journal:  Ann Neurol       Date:  2005-06       Impact factor: 10.422

4.  Structure of the human 80S ribosome.

Authors:  Heena Khatter; Alexander G Myasnikov; S Kundhavai Natchiar; Bruno P Klaholz
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

Review 5.  Defects in trafficking bridge Parkinson's disease pathology and genetics.

Authors:  Asa Abeliovich; Aaron D Gitler
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 6.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 7.  Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.

Authors:  Mark R Cookson
Journal:  Biochem Soc Trans       Date:  2016-12-15       Impact factor: 5.407

Review 8.  Oxidative stress and energy crises in neuronal dysfunction.

Authors:  David G Nicholls
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Software for computing and annotating genomic ranges.

Authors:  Michael Lawrence; Wolfgang Huber; Hervé Pagès; Patrick Aboyoun; Marc Carlson; Robert Gentleman; Martin T Morgan; Vincent J Carey
Journal:  PLoS Comput Biol       Date:  2013-08-08       Impact factor: 4.475

10.  The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments.

Authors:  Nicholas T Ingolia; Gloria A Brar; Silvia Rouskin; Anna M McGeachy; Jonathan S Weissman
Journal:  Nat Protoc       Date:  2012-07-26       Impact factor: 13.491

View more
  9 in total

Review 1.  Induced pluripotent stem cells: a tool for modeling Parkinson's disease.

Authors:  Anindita Bose; Gregory A Petsko; Lorenz Studer
Journal:  Trends Neurosci       Date:  2022-06-03       Impact factor: 16.978

2.  Dopamine neuron-specific LRRK2 G2019S effects on gene expression revealed by translatome profiling.

Authors:  Judit Pallos; Sophia Jeng; Shannon McWeeney; Ian Martin
Journal:  Neurobiol Dis       Date:  2021-05-11       Impact factor: 5.996

3.  Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons.

Authors:  Xiling Yin; Jungwoo Wren Kim; Shiyu Liu; Ted M Dawson; Valina L Dawson
Journal:  STAR Protoc       Date:  2021-03-23

Review 4.  The cell biology of Parkinson's disease.

Authors:  Nikhil Panicker; Preston Ge; Valina L Dawson; Ted M Dawson
Journal:  J Cell Biol       Date:  2021-04-05       Impact factor: 10.539

Review 5.  LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights.

Authors:  Patrick D Skelton; Valerie Tokars; Loukia Parisiadou
Journal:  Cells       Date:  2022-01-05       Impact factor: 7.666

6.  Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains.

Authors:  Jungwoo Wren Kim; Xiling Yin; Ian Martin; Yulan Xiong; Stephen M Eacker; Nicholas T Ingolia; Ted M Dawson; Valina L Dawson
Journal:  eNeuro       Date:  2021-11-30

Review 7.  Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review.

Authors:  Ailyn Irvita Ravinther; Hemaniswarri Dewi Dewadas; Shi Ruo Tong; Chai Nien Foo; Yu-En Lin; Cheng-Ting Chien; Yang Mooi Lim
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

Review 8.  Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.

Authors:  Leonie M Heger; Rachel M Wise; J Tabitha Hees; Angelika B Harbauer; Lena F Burbulla
Journal:  Cells       Date:  2021-12-07       Impact factor: 6.600

Review 9.  Patient-Specific iPSCs-Based Models of Neurodegenerative Diseases: Focus on Aberrant Calcium Signaling.

Authors:  Dmitriy A Grekhnev; Elena V Kaznacheyeva; Vladimir A Vigont
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.